business company limited by shares with BVI company number 524407 incorporated under the laws of the territory of the British Virgin Islands (“Capri” and, together with us and Merger Sub, the “Parties”) entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which and subject to the terms and conditions therein, Merger Sub would be merged with and into Capri (the “Merger”), with Capri surviving the Merger as a wholly owned subsidiary of the Company.
On November 13, 2024, the Parties entered into a Termination Agreement (the “Termination Agreement”), pursuant to which the Parties agreed that the Merger Agreement, including all schedules, annexes and exhibits thereto, was terminated (the “Termination Date”), effective immediately. Pursuant to the Termination Agreement, the Company reimbursed Capri for its expenses in an amount equal to approximately $45.1 million in cash on November 14, 2024. The Parties also agreed to release each other from claims, demands, damages, actions, causes of action and liability relating to or arising out of the Merger Agreement and the transactions contemplated therein or thereby.
On November 25, 2024, due to the termination of the Merger Agreement and pursuant to the terms of the Indenture, dated as of December 21, 2021, between the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee (the “Trustee”), as supplemented by: (i) with respect to the Company’s €500.0 million aggregate principal amount of 5.350% senior unsecured notes due 2025 (the “2025 EUR Notes”), €500.0 million aggregate principal amount of 5.375% senior unsecured notes due 2027 (the “2027 EUR Notes”) and €500.0 million aggregate principal amount of 5.875% senior unsecured notes due 2031 (the “2031 EUR Notes” and, together with the 2025 EUR Notes and the 2027 EUR Notes, the “EUR Notes”), the Third Supplemental Indenture, dated as of November 27, 2023, among the Company, the Trustee, and U.S. Bank Europe DAC, UK Branch (f.k.a. Elavon Financial Services DAC, UK Branch), as paying agent; and (ii) with respect to the Company’s $500.0 million aggregate principal amount of 7.050% senior unsecured notes due 2025 (the “2025 USD Notes”), $750.0 million aggregate principal amount of 7.000% senior unsecured notes due 2026 (the “2026 USD Notes”), $1,000.0 million aggregate principal amount of 7.350% senior unsecured notes due 2028 (the “2028 USD Notes”), $1,000.0 millionaggregate principal amount of 7.700% senior unsecured notes due 2030 (the “2030 USD Notes”) and $1,250.0 million aggregate principal amount of 7.850% senior unsecured notes due 2033 (the “2033 USD Notes” and, together with the 2025 USD Notes, the 2026 USD Notes, the 2028 USD Notes and the 2030 USD Notes, the “USD Notes”), the Second Supplemental Indenture, dated as of November 27, 2023, between the Company and the Trustee, the Company redeemed all outstanding EUR Notes and USD Notes at a redemption price of 101% of the aggregate principal amount of such EUR Notes and USD Notes, plus accrued and unpaid interest to, but excluding, the date of redemption (such redemption, the “Special Mandatory Redemption”). The Company funded the Special Mandatory Redemption with cash on hand.
Accelerated Share Repurchase Program
On November 13, 2024, our board of directors (the “Board”) authorized us to repurchase up to $2,000.0 million of our outstanding shares of common stock, $0.01 par value per share (the “Common Stock”), pursuant to a new share repurchase program. Under the share repurchase program, we may repurchase shares on the open market, in privately negotiated transactions or in other transactions, including accelerated share repurchase programs.
On November 21, 2024, we entered into accelerated share repurchase agreements (the “ASR Agreements”) with Bank of America, N.A. and Morgan Stanley & Co. LLC to repurchase an aggregate of up to $2,000.0 million of our outstanding shares of Common Stock. The Company funded the share repurchases under the ASR Agreements with $750.0 million of borrowings under the Term Loan Credit Agreement (as defined below), $1,000.0 million of borrowings under the Revolving Credit Facility (as defined under “Description of Other Indebtedness”) and cash on hand. After giving effect to the ASR Agreements, there will be $800.0 million of remaining availability for share repurchases under the share repurchase program authorized by the Board in May 2022.
Term Loan Credit Agreement
On November 21, 2024, in order to partially finance the share repurchases under the ASR Agreements, the Company and certain of its subsidiaries entered into a new $750.0 million senior unsecured term loan facility pursuant to that certain Term Loan Credit Agreement (the “Term Loan Credit Agreement”) with Bank of America, N.A., as administrative agent, and the lenders party thereto, and appointed BofA Securities, Inc. and Morgan Stanley Senior Lending, Inc. as joint lead arrangers and joint bookrunners. On November 26, 2024, we drew down in full the $750.0 million principal amount of loans under the Term Loan Credit Agreement.